In short
The American Brain Tumor Association (ABTA) permits generative AI in grant applications. Applicants are fully responsible for the content of their applications. The funder encourages them to review thoroughly anything an AI tool creates. For Metastatic Brain Tumor Collaborative grants, publishable content such as the lay summary must be written by the applicant or by others on the project, or built from information they wrote. Reviewers for these grants may not use AI to analyze, summarize, interpret, or critique applications.
Permits AI. Applicants may use AI and stay responsible for what they submit.
For applicants
- ABTA grant applications may use generative AI. Applicants are fully responsible for what their applications contain. The funder encourages them to review thoroughly any content an AI tool creates. [1]
- For Metastatic Brain Tumor Collaborative grants, publishable content such as the lay summary must be authored by the applicant or by others working on the project. It may also be developed from information those people authored. [2]
For reviewers
- For Metastatic Brain Tumor Collaborative grants, review committee chairs and reviewers may not use AI to analyze applications or to write peer review critiques. This covers scientific reviewers and patient advocate reviewers. It also covers using AI to summarize an application or to interpret the information in it. [2]
Sources
ABTA Research Collaboration Grants (opens in a new tab)
The use of Generative Artificial Intelligence (AI) is allowed for ABTA grant applications. Applicants are fully responsible for the content of their applications and are encouraged to thoroughly review any content created by an AI tool.
Policies and Procedures for 2027 Metastatic Brain Tumor Collaborative Grants (opens in a new tab)
Any publishable content (i.e. lay summary) MUST be authored by, or developed using information authored by, the Applicant or others working on the project.
Review Committee Chairpersons and Reviewers, including Scientific Reviewers and Patient Advocate Reviewers, are not permitted to use AI technologies for analyzing and formulating peer review critiques for grant applications, including for the purpose of summarizing the application or for interpreting the information in the application.
See American Brain Tumor Association's 1 open program
This page summarizes what the funder has published and is not legal advice. Policies change, and one solicitation can add its own rules. Confirm against the funding announcement before you apply.